Companies

Jade Biosciences, Inc. (JBIO) SEC filings

CIK 0001798749 · Pharmaceutical Preparations (SIC 2834) · Nasdaq · incorporated in DE · fiscal year ends 12/31

Annual financials (from the company's own XBRL in its 10-K filings)

FY2025FY2024FY2023
Net income (USD)-127.4 M-69.6 M-51.5 M
Diluted EPS (USD/shares)-3.19-2.44-2.1

Latest filings

FiledFormDescriptionPeriod
2026-09-308-K8-K items 8.012026-09-30
2026-08-14SCHEDULE 13G/ASCHEDULE 13G/A
2026-08-14SCHEDULE 13G/ASCHEDULE 13G/A
2026-08-1010-Q10-Q2026-06-30
2026-08-108-K8-K items 2.02,9.012026-08-10
2026-07-17SCHEDULE 13GSCHEDULE 13G
2026-07-08SCHEDULE 13G/ASCHEDULE 13G/A
2026-07-018-K8-K items 1.012026-06-29
2026-06-26442026-06-25
2026-06-26332026-06-25
2026-06-268-K8-K items 5.02,7.01,9.012026-06-25
2026-06-11442026-06-09
2026-06-11442026-06-09
2026-06-11442026-06-09
2026-06-11442026-06-09
2026-06-11442026-06-09
2026-06-118-K8-K items 5.03,5.07,9.012026-06-08
2026-06-09SCHEDULE 13D/ASCHEDULE 13D/A
2026-06-05DEFA14ADEFA14A
2026-06-048-K8-K items 8.01,9.012026-06-03
2026-06-04424B5424B5
2026-06-03424B5424B5
2026-06-018-K8-K items 7.01,8.01,9.012026-06-01
2026-05-15EFFECTEFFECT items ,,
2026-05-15EFFECTEFFECT items ,,

Forms on file (last 1,000): 4 184, 8-K 59, 144 52, 3 30, 425 17, 10-Q 16, CORRESP 14, SCHEDULE 13G/A 13. Source: SEC EDGAR, as filed; this page is public data and not investment advice.

For software and AI agents: the same data as JSON, per call, no account: GET https://store.agentexchange.work/gw/filings/company?ticker=JBIO (0.002 USD), /gw/filings/filings?ticker=JBIO&form=8-K, /gw/filings/facts?ticker=JBIO&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txt

Updated from EDGAR within 30 minutes of a filing. Agent Exchange